IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Operating income 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) annual operating income history from SEC filings — each fiscal year as reported.
-$403.4MFY2025 · since FY2016: -$53.6M → -$403.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$403.4M | -2.0% |
| FY2024 | -$395.3M | +14.2% |
| FY2023 | -$460.6M | -15.5% |
| FY2022 | -$398.9M | -16.4% |
| FY2021 | -$342.7M | -30.8% |
| FY2020 | -$261.9M | -26.6% |
| FY2019 | -$206.9M | -61.3% |
| FY2018 | -$128.3M | -38.1% |
| FY2017 | -$92.9M | -73.2% |
| FY2016 | -$53.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IOVA financial trends
IOVA RevenueIOVA Net incomeIOVA Net marginIOVA Gross profitIOVA Gross marginIOVA Operating marginIOVA Operating cash flowIOVA Free cash flowIOVA Capital expendituresIOVA Return on equityIOVA Stock buybacksIOVA Dividends paidIOVA Total assetsIOVA Total liabilitiesIOVA Shareholders’ equityIOVA overview →